Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering
- PMID: 24675426
- PMCID: PMC5380110
- DOI: 10.1038/srep04513
Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering
Abstract
The CRISPR/Cas system, in which the Cas9 endonuclease and a guide RNA complementary to the target are sufficient for RNA-guided cleavage of the target DNA, is a powerful new approach recently developed for targeted gene disruption in various animal models. However, there is little verification of microinjection methods for generating knockout mice using this approach. Here, we report the verification of microinjection methods of the CRISPR/Cas system. We compared three methods for injection: (1) injection of DNA into the pronucleus, (2) injection of RNA into the pronucleus, and (3) injection of RNA into the cytoplasm. We found that injection of RNA into the cytoplasm was the most efficient method in terms of the numbers of viable blastocyst stage embryos and full-term pups generated. This method also showed the best overall knockout efficiency.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells.G3 (Bethesda). 2016 Jul 7;6(7):2051-61. doi: 10.1534/g3.116.030601. G3 (Bethesda). 2016. PMID: 27175020 Free PMC article.
-
A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice.BMC Biotechnol. 2014 Jul 21;14:69. doi: 10.1186/1472-6750-14-69. BMC Biotechnol. 2014. PMID: 25042988 Free PMC article.
-
Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.BMC Biotechnol. 2015 May 22;15:33. doi: 10.1186/s12896-015-0144-x. BMC Biotechnol. 2015. PMID: 25997509 Free PMC article.
-
Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.Endocr J. 2016;63(3):213-9. doi: 10.1507/endocrj.EJ15-0734. Epub 2016 Jan 6. Endocr J. 2016. PMID: 26743444 Review.
-
Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.Dev Growth Differ. 2014 Jan;56(1):46-52. doi: 10.1111/dgd.12110. Epub 2013 Dec 27. Dev Growth Differ. 2014. PMID: 24372523 Review.
Cited by 53 articles
-
Recent Advances in CRISPR/Cas9 Delivery Strategies.Biomolecules. 2020 May 30;10(6):839. doi: 10.3390/biom10060839. Biomolecules. 2020. PMID: 32486234 Free PMC article. Review.
-
A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing.Theranostics. 2020 Apr 15;10(12):5532-5549. doi: 10.7150/thno.43465. eCollection 2020. Theranostics. 2020. PMID: 32373229 Free PMC article. Review.
-
Modification of i-GONAD Suitable for Production of Genome-Edited C57BL/6 Inbred Mouse Strain.Cells. 2020 Apr 13;9(4):957. doi: 10.3390/cells9040957. Cells. 2020. PMID: 32295056 Free PMC article.
-
Recent Advances and Future Perspectives of In Vivo Targeted Delivery of Genome-Editing Reagents to Germ Cells, Embryos, and Fetuses in Mice.Cells. 2020 Mar 26;9(4):799. doi: 10.3390/cells9040799. Cells. 2020. PMID: 32225003 Free PMC article. Review.
-
Sequential i-GONAD: An Improved In Vivo Technique for CRISPR/Cas9-Based Genetic Manipulations in Mice.Cells. 2020 Feb 26;9(3):546. doi: 10.3390/cells9030546. Cells. 2020. PMID: 32110989 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources